Márquez-Rodas Iván, Martín González Manuel, Nagore Eduardo, Gómez-Fernández Cristina, Avilés-Izquierdo Jose Antonio, Maldonado-Seral Cayetana, Soriano Virtudes, Majem-Tarruella Margarita, Palomar Virginia, Maseda Rocio, Martín-Carnicero Alfonso, Puertolas Teresa, Godoy Elena, Cerezuela Pablo, Ochoa de Olza Maria, Campos Begoña, Perez-Ruiz Elisabeth, Soria Ainara, Gil-Arnaiz Irene, Gonzalez-Cao Maria, Galvez Elisa, Arance Ana, Belon Joaquin, de la Cruz-Merino Luis, Martín-Algarra Salvador
Servicio de Oncología Médica, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, Spain.
PLoS One. 2015 Apr 13;10(4):e0124239. doi: 10.1371/journal.pone.0124239. eCollection 2015.
Familial history of melanoma is a well-known risk factor for the disease, and 7% melanoma patients were reported to have a family history of melanoma. Data relating to the frequency and clinical and pathological characteristics of both familial and non-familial melanoma in Spain have been published, but these only include patients from specific areas of Spain and do not represent the data for the whole of Spain.
An observational study conducted by the Spanish Group of Melanoma (GEM) analyzed the family history of patients diagnosed with melanoma between 2011 and 2013 in the dermatology and oncology departments.
In all, 1047 patients were analyzed, and 69 (6.6%) fulfilled criteria for classical familial melanoma (two or more first-degree relatives diagnosed with melanoma). Taking into account other risk factors for familial melanoma, such as multiple melanoma, pancreatic cancer in the family or second-degree relatives with melanoma, the number of patients fulfilling the criteria increased to 165 (15.8%). Using a univariate analysis, we determined that a Breslow index of less than 1 mm, negative mitosis, multiple melanoma, and a history of sunburns in childhood were more frequent in familial melanoma patients, but a multivariate analysis revealed no differences in any pathological or clinical factor between the two groups.
Similar to that observed in other countries, familial melanoma accounts for 6.6% of melanoma diagnoses in Spain. Although no differences in the multivariate analysis were found, some better prognosis factors, such as Breslow index, seem more frequent in familial melanoma, which reflect a better early detection marker and/or a different biological behavior.
黑色素瘤家族史是该疾病一个众所周知的风险因素,据报道7%的黑色素瘤患者有黑色素瘤家族史。关于西班牙家族性和非家族性黑色素瘤的发病率以及临床和病理特征的数据已经发表,但这些数据仅包括西班牙特定地区的患者,并不代表整个西班牙的数据。
西班牙黑色素瘤研究小组(GEM)进行的一项观察性研究分析了2011年至2013年间在皮肤科和肿瘤科诊断为黑色素瘤的患者的家族史。
总共分析了1047例患者,其中69例(6.6%)符合经典家族性黑色素瘤的标准(两个或更多一级亲属被诊断为黑色素瘤)。考虑到家族性黑色素瘤的其他风险因素,如多发性黑色素瘤、家族性胰腺癌或有黑色素瘤的二级亲属,符合标准的患者数量增加到165例(15.8%)。通过单因素分析,我们确定家族性黑色素瘤患者中Breslow指数小于1mm、有丝分裂阴性、多发性黑色素瘤以及儿童期晒伤史更为常见,但多因素分析显示两组在任何病理或临床因素上均无差异。
与其他国家观察到的情况类似,家族性黑色素瘤占西班牙黑色素瘤诊断病例的6.6%。虽然在多因素分析中未发现差异,但一些预后较好的因素,如Breslow指数,在家族性黑色素瘤中似乎更为常见,这反映了更好的早期检测标志物和/或不同的生物学行为。